Status:
UNKNOWN
Pharmacogenetics in Primary Care Psychotropics
Lead Sponsor:
University of Arizona
Conditions:
Depression
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Pragmatic trial of pharmacogenetic testing at the time of prescription for a selective serotonin reuptake inhibitor, tricyclic antidepressant or atypical antipsychotic. Does real time intervention imp...
Eligibility Criteria
Inclusion
- Over 18
- Prescribed a drug of interest for the first time
Exclusion
- Previous pharmacogenetic testing available
Key Trial Info
Start Date :
August 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2018
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03232502
Start Date
August 15 2017
End Date
December 31 2018
Last Update
July 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.